Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity

R. Y. van der Velde, C. E. Wyers, E. Teesselink, P. P. M. M. Geusens, J. P. W. van den Bergh, F. de Vries, C. Cooper*, N. C. Harvey, T. P. van Staa

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)50-55
Number of pages6
JournalBone
Volume94
DOIs
Publication statusPublished - Jan 2017

Keywords

  • Osteoporosis
  • Epidemiology
  • Anti-osteoporosis drugs
  • AOD
  • Fracture
  • Secular trends
  • RANDOMIZED CONTROLLED-TRIAL
  • PRACTICE RESEARCH DATABASE
  • POSTMENOPAUSAL WOMEN
  • HIP FRACTURE
  • PRIMARY-CARE
  • UK
  • POPULATION
  • RISK
  • BISPHOSPHONATES
  • DISPARITIES

Cite this